Tether Invests $200M in Majority Stake of Brain-Computer Interface Company Blackrock Neurotech

Tether's venture capital division, Tether Evo, has invested $200 million to acquire a majority stake in Blackrock Neurotech, a company that develops medical devices powered by brain signals to aid those impacted by paralysis and neurological disorders. The investment will fund the roll-out and commercialization of the devices and research and development purposes. Tether, the issuer of stablecoin USDT, has recently established four divisions to expand beyond stablecoin issuance and believes in nurturing emerging technologies with transformative capabilities. Paolo Ardoino, CEO of Tether, stated that Blackrock Neurotech's brain-computer-interfaces have the potential to open new realms of communication, rehabilitation, and cognitive enhancement.